PB

Pravin Bhadabhai Madhani

Active Director Director DIN 00370791
DIN 00370791 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2007
Shareholding value •••• Premium profile

About Pravin Bhadabhai Madhani

Data last updated:

Pravin Bhadabhai Madhani is a Director at Infinium Pharmachem Limited (since 2013), Director at Infinium Healthcare Private Limited (since 2015) and Director at Infinium Green Energy Private Limited (since 2022). The companies operate in Pharma, Environment and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹166 Cr; the largest is Infinium Pharmachem Limited at ₹158 Cr (FY 2025). Earlier, Pravin Bhadabhai Madhani was a Director at Aastrid Synthons Private Limited (2007–2010).

DIN 00370791
Primary Designation Director
Industry Pharma
First Appointment 01 May 2007
Oldest Company Age 22 yrs
Largest company Infinium Pharmachem Limited · ₹158 Cr (FY 2025)
Combined revenue ₹166 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Infinium Pharmachem Limited L24231GJ2003PLC043218
Director01 Dec 20132003₹158 Cr (FY 2025)Active
Infinium Healthcare Private Limited U24100GJ2015PTC084662
Director05 Oct 20152015₹5.21 Cr (FY 2025)Active
Director06 Jun 20222022₹3.40 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aastrid Synthons Private Limited U24232GJ2007PTC050713
Director01 May 20072007₹2,036 (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Infinium Healthcare Private Limited
Infinium Pharmachem Limited
Infinium Green Energy Private Limited
Aastrid Synthons Private Limited
Premium access

Shareholding and investment profile for Pravin Bhadabhai Madhani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Bhadabhai Madhani

Pravin Bhadabhai Madhani currently holds 3 directorships: Infinium Pharmachem Limited (Director, since 01 Dec 2013, revenue ₹158 Cr (FY 2025)); Infinium Healthcare Private Limited (Director, since 05 Oct 2015, revenue ₹5.21 Cr (FY 2025)); Infinium Green Energy Private Limited (Director, since 06 Jun 2022, revenue ₹3.40 Cr (FY 2025)).

Pravin Bhadabhai Madhani was first appointed on 01 May 2007 as Director at Aastrid Synthons Private Limited. The most recent appointment on record is 06 Jun 2022 at Infinium Green Energy Private Limited.

The 3 current companies of Pravin Bhadabhai Madhani that report revenue have a combined latest revenue of ₹166 Cr: Infinium Pharmachem Limited ₹158 Cr (FY 2025); Infinium Healthcare Private Limited ₹5.21 Cr (FY 2025); Infinium Green Energy Private Limited ₹3.40 Cr (FY 2025).

Pravin Bhadabhai Madhani held 1 earlier board appointment: Aastrid Synthons Private Limited (Director, 01 May 2007 to 27 Nov 2010).

The current boards of Pravin Bhadabhai Madhani's companies include Keyur Jagdishchandra Shah (Infinium Pharmachem Limited), Kunj Anjaykumar Desai (Infinium Pharmachem Limited), Mitesh Lavjibhai Chikhaliya (Infinium Pharmachem Limited), Sanjaykumar Viththalbhai Patel (Infinium Pharmachem Limited), Tarun Ratilal Dobariya (Infinium Pharmachem Limited), Vaishakhi Ambrishbhai Shukla (Infinium Pharmachem Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available